786 results on '"Zivanovic, Oliver"'
Search Results
152. Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer
153. Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer
154. The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum
155. Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma
156. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas
157. Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary study
158. Digital Technical and Informal Resources of Breast Cancer Patients From 2012 to 2020: Questionnaire-Based Longitudinal Trend Study
159. HIPEC ROC I: A phase i study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer
160. Improving sentinel lymph node detection rates in endometrial cancer: How many cases are needed?
161. Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer
162. Advanced cytoreductive surgery: American perspective
163. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
164. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma
165. Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
166. Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
167. Use of indocyanine green for sentinel lymph node biopsy in patients with iodine or contrast allergy
168. A modern day experience with Brunschwig's operation: advancements in pelvic exenteration
169. 10-year survival in patients diagnosed with high-grade epithelial ovarian cancer: a new metric for a new millennium
170. Quaternary and beyond cytoreduction: An updated and expanded analysis
171. Digital Technical and Informal Resources of Breast Cancer Patients From 2012 to 2020: Questionnaire-Based Longitudinal Trend Study
172. Pharmaceutical care for patients with breast and ovarian cancer
173. Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy
174. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma
175. The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease
176. Retroperitoneal lymph node dissection (RPLND)
177. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer
178. Cytoreductive surgery for advanced ovarian cancer
179. Capítulo 17 - Resección y anastomosis del intestino delgado y el intestino grueso
180. Influence of preoperative MRI on the surgical management of patients with operable breast cancer
181. Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer
182. Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer (187)
183. Leave it in the past: Primary treatment modality for high-grade epithelial ovarian cancer does not affect secondary cytoreduction outcomes (173)
184. Patient-reported symptoms after debulking surgery and associations with urgent care visits, readmissions, and complications (161)
185. Analysis of three prediction models for complete gross resection in secondary cytoreductive surgery for platinum-sensitive ovarian cancer (063)
186. Minimizing futile laparotomies at primary cytoreduction for advanced ovarian cancer: A feasibility study comparing management algorithms (023)
187. A feasibility study for mapping ovarian sentinel lymph nodes: Does location of injection matter? (022)
188. Centralizing cytoreductive surgery for ovarian cancer to high-volume centers: What is the impact of travel on patients? (2207)
189. Modern associations of uterine carcinomas with prior exposure to tamoxifen (2144)
190. Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes (1242)
191. To operate or not to operate?: Preoperative factors associated with unsuccessful palliation following surgery for malignant bowel obstruction in patients with recurrent ovarian cancer (1232)
192. Impact of postoperative morbidity on oncologic outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery (1206)
193. Perioperative percent change in CA-125 in patients with high grade serous ovarian cancer undergoing primary cytoreductive surgery with complete gross resection (1205)
194. MRI of the pelvis at 3 T: very high spatial resolution with sensitivity encoding and flip-angle sweep technique in clinically acceptable scan time
195. Retroperitoneal Lymph Node Dissection
196. Why was GOG-0213 a negative trial?
197. Interval Debulking Surgery in Patients with Federation of Gynecology and Obstetrics (FIGO) Stage IIIC and IV Ovarian Cancer
198. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma
199. ‘Ultra-radical’ surgery in advanced ovarian cancer
200. Advanced cytoreductive surgery program development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.